If genetic variation could talk: What genomic data may teach us about the importance of gene expression regulation in the genetics of autism

Molecular and Cellular Probes

Volumn 30, Issue 6, 2016, Pages 346-356

  Yeh, Erika ^a   Weiss, Lauren A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism spectrum disorder; Gene expression; Gene mapping; Molecular pathology

Indexed keywords

BIOLOGICAL MARKER;

AUTISM; CHROMOSOME ABERRATION; COPY NUMBER VARIATION; EXOME; GENE EXPRESSION REGULATION; GENE MAPPING; GENE SEQUENCE; GENETIC LINKAGE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMAN; MONOGENIC DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEQUENCE ANALYSIS; BRAIN; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

AUTISTIC DISORDER; BRAIN; CHROMOSOME ABERRATIONS; DNA COPY NUMBER VARIATIONS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS;

EID: 84997530248     PISSN: 08908508     EISSN: 10961194     Source Type: Journal    
DOI: 10.1016/j.mcp.2016.10.007     Document Type: Review

References (188)

1. [1] Abrams, N., Pergament, E., Childhood psychosis combined with XYY abnormalities. J. Genet. Psychol. 118 (1971), 13–16.
2. [2] Adamo, A., Atashpaz, S., Germain, P.L., Zanella, M., D'Agostino, G., Albertin, V., Chenoweth, J., Micale, L., Fusco, C., Unger, C., et al. 7q11.23 dosage-dependent dysregulation in human pluripotent stem cells affects transcriptional programs in disease-relevant lineages. Nat. Genet. 47 (2015), 132–141.
3. [3] Adviento, B., Corbin, I.L., Widjaja, F., Desachy, G., Enrique, N., Rosser, T., Risi, S., Marco, E.J., Hendren, R.L., Bearden, C.E., et al. Autism traits in the RASopathies. J. Med. Genet. 51 (2014), 10–20.
4. [4] Aldred, S., Moore, K.M., Fitzgerald, M., Waring, R.H., Plasma amino acid levels in children with autism and their families. J. Autism Dev. Disord. 33 (2003), 93–97.
5. [5] Altshuler, D., Hirschhorn, J.N., Klannemark, M., Lindgren, C.M., Vohl, M.C., Nemesh, J., Lane, C.R., Schaffner, S.F., Bolk, S., Brewer, C., et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26 (2000), 76–80.
6. [6] Amaral, D.G., Schumann, C.M., Nordahl, C.W., Neuroanatomy of autism. Trends Neurosci. 31 (2008), 137–145.
7. [7] American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders: DSM-5. fifth ed., 2013, American Psychiatric Association, Arlington, VA.
8. [8] Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U., Zoghbi, H.Y., Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23 (1999), 185–188.
9. [9] Anney, R., Klei, L., Pinto, D., Almeida, J., Bacchelli, E., Baird, G., Bolshakova, N., Bolte, S., Bolton, P.F., Bourgeron, T., et al. Individual common variants exert weak effects on the risk for autism spectrum disorders. Hum. Mol. Genet. 21 (2012), 4781–4792.
10. [10] Anney, R., Klei, L., Pinto, D., Regan, R., Conroy, J., Magalhaes, T.R., Correia, C., Abrahams, B.S., Sykes, N., Pagnamenta, A.T., et al. A genome-wide scan for common alleles affecting risk for autism. Hum. Mol. Genet. 19 (2010), 4072–4082.
11. [11] Arbogast, T., Ouagazzal, A.M., Chevalier, C., Kopanitsa, M., Afinowi, N., Migliavacca, E., Cowling, B.S., Birling, M.C., Champy, M.F., Reymond, A., Herault, Y., Reciprocal effects on neurocognitive and metabolic phenotypes in mouse models of 16p11.2 deletion and duplication syndromes. PLoS Genet., 12, 2016, e1005709.
12. [12] Arking, D.E., Cutler, D.J., Brune, C.W., Teslovich, T.M., West, K., Ikeda, M., Rea, A., Guy, M., Lin, S., Cook, E.H., Chakravarti, A., A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am. J. Hum. Genet. 82 (2008), 160–164.
13. [13] Ascano, M. Jr., Mukherjee, N., Bandaru, P., Miller, J.B., Nusbaum, J.D., Corcoran, D.L., Langlois, C., Munschauer, M., Dewell, S., Hafner, M., et al. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature 492 (2012), 382–386.
14. [14] Ashley-Koch, A., Wolpert, C.M., Menold, M.M., Zaeem, L., Basu, S., Donnelly, S.L., Ravan, S.A., Powell, C.M., Qumsiyeh, M.B., Aylsworth, A.S., et al. Genetic studies of autistic disorder and chromosome 7. Genomics 61 (1999), 227–236.
15. [15] Autism Genome Project, C., Szatmari, P., Paterson, A.D., Zwaigenbaum, L., Roberts, W., Brian, J., Liu, X.Q., Vincent, J.B., Skaug, J.L., Thompson, A.P., et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 39 (2007), 319–328.
16. [16] Baker, P., Piven, J., Schwartz, S., Patil, S., Brief report: duplication of chromosome 15q11-13 in two individuals with autistic disorder. J. Autism Dev. Disord. 24 (1994), 529–535.
17. [17] Baron-Cohen, S., Scott, F.J., Allison, C., Williams, J., Bolton, P., Matthews, F.E., Brayne, C., Prevalence of autism-spectrum conditions: UK school-based population study. Br. J. Psychiatry 194 (2009), 500–509.
18. [18] Barrett, S., Beck, J.C., Bernier, R., Bisson, E., Braun, T.A., Casavant, T.L., Childress, D., Folstein, S.E., Garcia, M., Gardiner, M.B., et al. An autosomal genomic screen for autism. Collaborative linkage study of autism. Am. J. Med. Genet. 88 (1999), 609–615.
19. [19] Bauman, M.L., Kemper, T.L., The neuropathology of the autism spectrum disorders: what have we learned?. Novartis Foundation Symposium 251, 112-122; Discussion 122-118, 281–197, 2003.
20. [20] Beckmann, J.S., Antonarakis, S.E., Lessons from the Genome-wide Association Studies for Complex Multifactorial Disorders and Traits. Lessons from the Genome-Wide Association Studies for Complex Multifactorial Disorders and Traits, 2010, 287–297.
21. [21] Belmonte, M.K., Cook, E.H. Jr., Anderson, G.M., Rubenstein, J.L., Greenough, W.T., Beckel-Mitchener, A., Courchesne, E., Boulanger, L.M., Powell, S.B., Levitt, P.R., et al. Autism as a disorder of neural information processing: directions for research and targets for therapy. Mol. psychiatry 9 (2004), 646–663.
22. [22] Ben-David, E., Shifman, S., Combined analysis of exome sequencing points toward a major role for transcription regulation during brain development in autism. Mol. psychiatry 18 (2013), 1054–1056.
23. [23] Ben-Shachar, S., Lanpher, B., German, J.R., Qasaymeh, M., Potocki, L., Nagamani, S.C., Franco, L.M., Malphrus, A., Bottenfield, G.W., Spence, J.E., et al. Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J. Med. Genet. 46 (2009), 382–388.
24. [24] Berg, J.M., Geschwind, D.H., Autism genetics: searching for specificity and convergence. Genome Biol., 13, 2012, 247.
25. [25] Berg, J.S., Brunetti-Pierri, N., Peters, S.U., Kang, S.H., Fong, C.T., Salamone, J., Freedenberg, D., Hannig, V.L., Prock, L.A., Miller, D.T., et al. Speech delay and autism spectrum behaviors are frequently associated with duplication of the 7q11.23 Williams-Beuren syndrome region. Genet. Med. 9 (2007), 427–441.
26. [26] Bernier, R., Golzio, C., Xiong, B., Stessman, H.A., Coe, B.P., Penn, O., Witherspoon, K., Gerdts, J., Baker, C., Vulto-van Silfhout, A.T., et al. Disruptive CHD8 mutations define a subtype of autism early in development. Cell 158 (2014), 263–276.
27. [27] Blaker-Lee, A., Gupta, S., McCammon, J.M., De Rienzo, G., Sive, H., Zebrafish homologs of genes within 16p11.2, a genomic region associated with brain disorders, are active during brain development, and include two deletion dosage sensor genes. Dis. Model. Mech. 5 (2012), 834–851.
28. [28] Blau, N., Genetics of phenylketonuria: then and now. Hum. Mutat. 37 (2016), 508–515.
29. [29] Brown, W.T., Jenkins, E.C., Friedman, E., Brooks, J., Wisniewski, K., Raguthu, S., French, J., Autism is associated with the fragile-X syndrome. J. Autism Dev. Disord. 12 (1982), 303–308.
30. [30] Brunet, I., Weinl, C., Piper, M., Trembleau, A., Volovitch, M., Harris, W., Prochiantz, A., Holt, C., The transcription factor Engrailed-2 guides retinal axons. Nature 438 (2005), 94–98.
31. [31] Bucan, M., Abrahams, B.S., Wang, K., Glessner, J.T., Herman, E.I., Sonnenblick, L.I., Alvarez Retuerto, A.I., Imielinski, M., Hadley, D., Bradfield, J.P., et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet., 5, 2009, e1000536.
32. [32] Bundey, S., Hardy, C., Vickers, S., Kilpatrick, M.W., Corbett, J.A., Duplication of the 15q11-13 region in a patient with autism, epilepsy and ataxia. Dev. Med. Child Neurol. 36 (1994), 736–742.
33. [33] Bush, W.S., Haines, J., Overview of linkage analysis in complex traits. Curr. Protoc. Hum. Genet./Editor. Board 9 (2010), 1–18 Jonathan L Haines [et al] Chapter 1, Unit 1.
34. [34] Buxbaum, J.D., Silverman, J.M., Smith, C.J., Greenberg, D.A., Kilifarski, M., Reichert, J., Cook, E.H. Jr., Fang, Y., Song, C.Y., Vitale, R., Association between a GABRB3 polymorphism and autism. Mol. Psychiatry 7 (2002), 311–316.
35. [35] Buxhoeveden, D.P., Semendeferi, K., Buckwalter, J., Schenker, N., Switzer, R., Courchesne, E., Reduced minicolumns in the frontal cortex of patients with autism. Neuropathol. Appl. Neurobiol. 32 (2006), 483–491.
36. [36] Carter, M.T., Scherer, S.W., Autism spectrum disorder in the genetics clinic: a review. Clin. Genet. 83 (2013), 399–407.
37. [37] Casanova, M.F., The neuropathology of autism. Brain Pathol. 17 (2007), 422–433.
38. [38] Castermans, D., Wilquet, V., Steyaert, J., Van de Ven, W., Fryns, J.P., Devriendt, K., Chromosomal anomalies in individuals with autism: a strategy towards the identification of genes involved in autism. Autism 8 (2004), 141–161.
39. [39] Ch'ng, T.H., Martin, K.C., Synapse-to-nucleus signaling. Curr. Opin. Neurobiol. 21 (2011), 345–352.
40. [40] Chailangkarn, T., Trujillo, C.A., Freitas, B.C., Hrvoj-Mihic, B., Herai, R.H., Yu, D.X., Brown, T.T., Marchetto, M.C., Bardy, C., McHenry, L., et al. A human neurodevelopmental model for Williams syndrome. Nature 536 (2016), 338–343.
41. [41] Chandana, S.R., Behen, M.E., Juhasz, C., Muzik, O., Rothermel, R.D., Mangner, T.J., Chakraborty, P.K., Chugani, H.T., Chugani, D.C., Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int. J. Dev. Neurosci. Off. J. Int. Soc. Dev. Neurosci. 23 (2005), 171–182.
42. [42] Chaudhry, A., Noor, A., Degagne, B., Baker, K., Bok, L.A., Brady, A.F., Chitayat, D., Chung, B.H., Cytrynbaum, C., Dyment, D., et al. Phenotypic spectrum associated with PTCHD1 deletions and truncating mutations includes intellectual disability and autism spectrum disorder. Clin. Genet. 88 (2015), 224–233.
43. [43] Cheng, R., Lim, J.E., Samocha, K.E., Sokoloff, G., Abney, M., Skol, A.D., Palmer, A.A., Genome-wide association studies and the problem of relatedness among advanced intercross lines and other highly recombinant populations. Genetics 185 (2010), 1033–1044.
44. [44] Chugani, D.C., Muzik, O., Rothermel, R., Behen, M., Chakraborty, P., Mangner, T., da Silva, E.A., Chugani, H.T., Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann. Neurol. 42 (1997), 666–669.
45. [45] Cohen, S., Greenberg, M.E., Communication between the synapse and the nucleus in neuronal development, plasticity, and disease. Annu. Rev. Cell Dev. Biol. 24 (2008), 183–209.
46. [46] Consortium, I.M.G.S.o.A., A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Hum. Mol. Genet. 7 (1998), 571–578.
47. [47] Cook, E.H. Jr., Lindgren, V., Leventhal, B.L., Courchesne, R., Lincoln, A., Shulman, C., Lord, C., Courchesne, E., Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am. J. Hum. Genet. 60 (1997), 928–934.
48. [48] Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L., Pericak-Vance, M.A., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993), 921–923.
49. [49] Courchesne, E., Brain development in autism: early overgrowth followed by premature arrest of growth. Ment. Retard. Dev. Disabil. Res. Rev. 10 (2004), 106–111.
50. [50] Courchesne, E., Mouton, P.R., Calhoun, M.E., Semendeferi, K., Ahrens-Barbeau, C., Hallet, M.J., Barnes, C.C., Pierce, K., Neuron number and size in prefrontal cortex of children with autism. Jama 306 (2011), 2001–2010.
51. [51] Courchesne, E., Pierce, K., Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long-distance disconnection. Curr. Opin. Neurobiol. 15 (2005), 225–230.
52. [52] Courchesne, E., Redcay, E., Kennedy, D.P., The autistic brain: birth through adulthood. Curr. Opin. Neurol. 17 (2004), 489–496.
53. [53] Crandall, B.F., Carrel, R.E., Sparkes, R.S., Chromosome findings in 700 children referred to a psychiatric clinic. J. Pediatr. 80 (1972), 62–68.
54. [54] Dassano, A., Noci, S., Galbiati, F., Colombo, F., Trincucci, G., Pettinicchio, A., Dragani, T.A., Manenti, G., Multigenic nature of the mouse pulmonary adenoma progression 1 locus. BMC Genomics, 14, 2013, 152.
55. [55] De Rubeis, S., Bagni, C., Regulation of molecular pathways in the fragile X syndrome: insights into autism spectrum disorders. J. Neurodev. Disord. 3 (2011), 257–269.
56. [56] De Rubeis, S., He, X., Goldberg, A.P., Poultney, C.S., Samocha, K., Cicek, A.E., Kou, Y., Liu, L., Fromer, M., Walker, S., et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515 (2014), 209–215.
57. [57] Delorme, R., Ey, E., Toro, R., Leboyer, M., Gillberg, C., Bourgeron, T., Progress toward treatments for synaptic defects in autism. Nat. Med. 19 (2013), 685–694.
58. [58] Developmental Disabilities Monitoring Network Surveillance Year Principal, I., Centers for Disease, C., and Prevention, Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2010. 2014 MMWR Surveill Summ 63, 1–21.
59. [59] Doelken, S.C., Kohler, S., Mungall, C.J., Gkoutos, G.V., Ruef, B.J., Smith, C., Smedley, D., Bauer, S., Klopocki, E., Schofield, P.N., et al. Phenotypic overlap in the contribution of individual genes to CNV pathogenicity revealed by cross-species computational analysis of single-gene mutations in humans, mice and zebrafish. Dis. Model. Mech. 6 (2013), 358–372.
60. [60] Dong, S., Walker, M.F., Carriero, N.J., DiCola, M., Willsey, A.J., Ye, A.Y., Waqar, Z., Gonzalez, L.E., Overton, J.D., Frahm, S., et al. De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder. Cell Rep. 9 (2014), 16–23.
61. [61] Doyle-Thomas, K.A., Card, D., Soorya, L.V., Wang, A.T., Fan, J., Anagnostou, E., Metabolic mapping of deep brain structures and associations with symptomatology in autism spectrum disorders. Res. Autism Spectr. Disord. 8 (2014), 44–51.
62. [62] Duerr, R.H., Taylor, K.D., Brant, S.R., Rioux, J.D., Silverberg, M.S., Daly, M.J., Steinhart, A.H., Abraham, C., Regueiro, M., Griffiths, A., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 (2006), 1461–1463.
63. [63] Durand, C.M., Betancur, C., Boeckers, T.M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I.C., Anckarsater, H., et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39 (2007), 25–27.
64. [64] Eberhart, D.E., Malter, H.E., Feng, Y., Warren, S.T., The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum. Mol. Genet. 5 (1996), 1083–1091.
65. [65] El Achkar, C.M., Olson, H.E., Poduri, A., Pearl, P.L., The genetics of the epilepsies. Curr. Neurol. Neurosci. Rep., 15, 2015, 39.
66. [66] Fatemi, S.H., Folsom, T.D., Kneeland, R.E., Liesch, S.B., Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both Fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism. Anat. Rec. 294 (2011), 1635–1645.
67. [67] Feng, J., Schroer, R., Yan, J., Song, W., Yang, C., Bockholt, A., Cook, E.H. Jr., Skinner, C., Schwartz, C.E., Sommer, S.S., High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci. Lett. 409 (2006), 10–13.
68. [68] Fernandez, B.A., Roberts, W., Chung, B., Weksberg, R., Meyn, S., Szatmari, P., Joseph-George, A.M., Mackay, S., Whitten, K., Noble, B., et al. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. J. Med. Genet. 47 (2010), 195–203.
69. [69] Filipek, P.A., Juranek, J., Smith, M., Mays, L.Z., Ramos, E.R., Bocian, M., Masser-Frye, D., Laulhere, T.M., Modahl, C., Spence, M.A., Gargus, J.J., Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Ann. Neurol. 53 (2003), 801–804.
70. [70] Folstein, S., Rutter, M., Infantile Autism: a genetic study of 21 twin pairs. J. Child Psychol. Psychiatry 18 (1977), 297–321.
71. [71] Fonseca, B.D., Smith, E.M., Yelle, N., Alain, T., Bushell, M., Pause, A., The ever-evolving role of mTOR in translation. Semin. Cell & Dev. Biol. 36 (2014), 102–112.
72. [72] Fung, L.K., Hardan, A.Y., Developing medications targeting glutamatergic dysfunction in autism: progress to date. CNS Drugs 29 (2015), 453–463.
73. [73] Gaugler, T., Klei, L., Sanders, S.J., Bodea, C.A., Goldberg, A.P., Lee, A.B., Mahajan, M., Manaa, D., Pawitan, Y., Reichert, J., et al. Most genetic risk for autism resides with common variation. Nat. Genet. 46 (2014), 881–885.
74. [74] Gauthier, J., Siddiqui, T.J., Huashan, P., Yokomaku, D., Hamdan, F.F., Champagne, N., Lapointe, M., Spiegelman, D., Noreau, A., Lafreniere, R.G., et al. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum. Genet. 130 (2011), 563–573.
75. [75] Geschwind, D.H., State, M.W., Gene hunting in autism spectrum disorder: on the path to precision medicine. Lancet Neurol. 14 (2015), 1109–1120.
76. [76] Gilman, S.R., Iossifov, I., Levy, D., Ronemus, M., Wigler, M., Vitkup, D., Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70 (2011), 898–907.
77. [77] Goffin, A., Hoefsloot, L.H., Bosgoed, E., Swillen, A., Fryns, J.P., PTEN mutation in a family with Cowden syndrome and autism. Am. J. Med. Genet. 105 (2001), 521–524.
78. [78] Golzio, C., Willer, J., Talkowski, M.E., Oh, E.C., Taniguchi, Y., Jacquemont, S., Reymond, A., Sun, M., Sawa, A., Gusella, J.F., et al. KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant. Nature 485 (2012), 363–367.
79. [79] Greer, P.L., Greenberg, M.E., From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron 59 (2008), 846–860.
80. [80] Gusella, J.F., Wexler, N.S., Conneally, P.M., Naylor, S.L., Anderson, M.A., Tanzi, R.E., Watkins, P.C., Ottina, K., Wallace, M.R., Sakaguchi, A.Y., et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306 (1983), 234–238.
81. [81] Gusev, A., Lee, S.H., Trynka, G., Finucane, H., Vilhjalmsson, B.J., Xu, H., Zang, C., Ripke, S., Bulik-Sullivan, B., Stahl, E., et al. Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. Am. J. Hum. Genet. 95 (2014), 535–552.
82. [82] Guzman-Ayala, M., Sachs, M., Koh, F.M., Onodera, C., Bulut-Karslioglu, A., Lin, C.J., Wong, P., Nitta, R., Song, J.S., Ramalho-Santos, M., Chd1 is essential for the high transcriptional output and rapid growth of the mouse epiblast. Development 142 (2015), 118–127.
83. [83] Hagberg, B., Aicardi, J., Dias, K., Ramos, O., A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: rett's syndrome: report of 35 cases. Ann. Neurol. 14 (1983), 471–479.
84. [84] Hallmayer, J., Cleveland, S., Torres, A., Phillips, J., Cohen, B., Torigoe, T., Miller, J., Fedele, A., Collins, J., Smith, K., et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch. General Psychiatry 68 (2011), 1095–1102.
85. [85] Holtmaat, A., Svoboda, K., Experience-dependent structural synaptic plasticity in the mammalian brain. Nat. Rev. Neurosci. 10 (2009), 647–658.
86. [86] Horev, G., Ellegood, J., Lerch, J.P., Son, Y.E., Muthuswamy, L., Vogel, H., Krieger, A.M., Buja, A., Henkelman, R.M., Wigler, M., Mills, A.A., Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 17076–17081.
87. [87] Hoshino, Y., Yashima, Y., Tachibana, R., Kaneko, M., Watanabe, M., Kumashiro, H., Sex chromosome abnormalities in autistic children–long Y chromosome. Fukushima J. Med. Sci. 26 (1979), 31–42.
88. [88] Hutsler, J.J., Casanova, M.F., Review: cortical construction in autism spectrum disorder: columns, connectivity and the subplate. Neuropathol. Appl. Neurobiol. 42 (2016), 115–134.
89. [89] International League Against Epilepsy Consortium on Complex Epilepsies, Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies. Lancet Neurol. 13 (2014), 893–903.
90. [90] International Molecular Genetic Study of Autism, C, A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am. J. Hum. Genet. 69 (2001), 570–581.
91. [91] Iossifov, I., O'Roak, B.J., Sanders, S.J., Ronemus, M., Krumm, N., Levy, D., Stessman, H.A., Witherspoon, K.T., Vives, L., Patterson, K.E., et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515 (2014), 216–221.
92. [92] Iossifov, I., Ronemus, M., Levy, D., Wang, Z., Hakker, I., Rosenbaum, J., Yamrom, B., Lee, Y.H., Narzisi, G., Leotta, A., et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74 (2012), 285–299.
93. [93] Isles, A.R., Ingason, A., Lowther, C., Walters, J., Gawlick, M., Stober, G., Rees, E., Martin, J., Little, R.B., Potter, H., et al. Parental origin of interstitial duplications at 15q11.2-q13.3 in schizophrenia and neurodevelopmental disorders. PLoS Genet., 12, 2016, e1005993.
94. [94] Itsara, A., Cooper, G.M., Baker, C., Girirajan, S., Li, J., Absher, D., Krauss, R.M., Myers, R.M., Ridker, P.M., Chasman, D.I., et al. Population analysis of large copy number variants and hotspots of human genetic disease. Am. J. Hum. Genet. 84 (2009), 148–161.
95. [95] Iyengar, S.K., Elston, R.C., The genetic basis of complex traits: rare variants or “common gene, common disease”?. Methods Mol. Biol. 376 (2007), 71–84.
96. [96] Jamain, S., Quach, H., Betancur, C., Rastam, M., Colineaux, C., Gillberg, I.C., Soderstrom, H., Giros, B., Leboyer, M., Gillberg, C., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34 (2003), 27–29.
97. [97] Johnston, M., Blue, M.E., Naidu, S., Recent advances in understanding synaptic abnormalities in Rett syndrome. F1000Research, 4, 2015.
98. [98] Judd, L.L., Mandell, A.J., Chromosome studies in early infantile autism. Arch. General Psychiatry 18 (1968), 450–457.
99. [99] Kane, M.J., Angoa-Perez, M., Briggs, D.I., Sykes, C.E., Francescutti, D.M., Rosenberg, D.R., Kuhn, D.M., Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to autism. PloS One, 7, 2012, e48975.
100. [100] Kim, S.J., Sung, J.Y., Um, J.W., Hattori, N., Mizuno, Y., Tanaka, K., Paik, S.R., Kim, J., Chung, K.C., Parkin cleaves intracellular alpha-synuclein inclusions via the activation of calpain. J. Biol. Chem. 278 (2003), 41890–41899.
101. [101] Kim, Y.S., Leventhal, B.L., Koh, Y.J., Fombonne, E., Laska, E., Lim, E.C., Cheon, K.A., Kim, S.J., Kim, Y.K., Lee, H., et al. Prevalence of autism spectrum disorders in a total population sample. Am. J. Psychiatry 168 (2011), 904–912.
102. [102] Klein, R.J., Zeiss, C., Chew, E.Y., Tsai, J.Y., Sackler, R.S., Haynes, C., Henning, A.K., SanGiovanni, J.P., Mane, S.M., Mayne, S.T., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005), 385–389.
103. [103] Kopp, N., Climer, S., Dougherty, J.D., Moving from capstones toward cornerstones: successes and challenges in applying systems biology to identify mechanisms of autism spectrum disorders. Front. Genet., 6, 2015, 301.
104. [104] Kotlar, A.V., Mercer, K.B., Zwick, M.E., Mulle, J.G., New discoveries in schizophrenia genetics reveal neurobiological pathways: a review of recent findings. Eur. J. Med. Genet. 58 (2015), 704–714.
105. [105] Kruglyak, L., Daly, M.J., Reeve-Daly, M.P., Lander, E.S., Parametric and nonparametric linkage analysis: a unified multipoint approach. Am. J. Hum. Genet. 58 (1996), 1347–1363.
106. [106] Krumm, N., Turner, T.N., Baker, C., Vives, L., Mohajeri, K., Witherspoon, K., Raja, A., Coe, B.P., Stessman, H.A., He, Z.X., et al. Excess of rare, inherited truncating mutations in autism. Nat. Genet. 47 (2015), 582–588.
107. [107] Lamb, J.A., Moore, J., Bailey, A., Monaco, A.P., Autism: recent molecular genetic advances. Hum. Mol. Genet. 9 (2000), 861–868.
108. [108] Lander, E.S., The new genomics: global views of biology. Science 274 (1996), 536–539.
109. [109] Langen, M., Durston, S., Staal, W.G., Palmen, S.J., van Engeland, H., Caudate nucleus is enlarged in high-functioning medication-naive subjects with autism. Biol. Psychiatry 62 (2007), 262–266.
110. [110] Langen, M., Schnack, H.G., Nederveen, H., Bos, D., Lahuis, B.E., de Jonge, M.V., van Engeland, H., Durston, S., Changes in the developmental trajectories of striatum in autism. Biol. Psychiatry 66 (2009), 327–333.
111. [111] Laplante, M., Sabatini, D.M., mTOR signaling at a glance. J. Cell Sci. 122 (2009), 3589–3594.
112. [112] Leblond, C.S., Heinrich, J., Delorme, R., Proepper, C., Betancur, C., Huguet, G., Konyukh, M., Chaste, P., Ey, E., Rastam, M., et al. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet., 8, 2012, e1002521.
113. [113] Legare, M.E., Bartlett, F.S. 2nd, Frankel, W.N., A major effect QTL determined by multiple genes in epileptic EL mice. Genome Res. 10 (2000), 42–48.
114. [114] Legare, M.E., Frankel, W.N., Multiple seizure susceptibility genes on chromosome 7 in SWXL-4 congenic mouse strains. Genomics 70 (2000), 62–65.
115. [116] Lim, E.T., Raychaudhuri, S., Sanders, S.J., Stevens, C., Sabo, A., MacArthur, D.G., Neale, B.M., Kirby, A., Ruderfer, D.M., Fromer, M., et al. Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron 77 (2013), 235–242.
116. [117] Lipton, J.O., Sahin, M., The neurology of mTOR. Neuron 84 (2014), 275–291.
117. [118] Liu, J., Nyholt, D.R., Magnussen, P., Parano, E., Pavone, P., Geschwind, D., Lord, C., Iversen, P., Hoh, J., Ott, J., et al. A genomewide screen for autism susceptibility loci. Am. J. Hum. Genet. 69 (2001), 327–340.
118. [119] Locke, A.E., Kahali, B., Berndt, S.I., Justice, A.E., Pers, T.H., Day, F.R., Powell, C., Vedantam, S., Buchkovich, M.L., Yang, J., et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518 (2015), 197–206.
119. [120] McCauley, J.L., Li, C., Jiang, L., Olson, L.M., Crockett, G., Gainer, K., Folstein, S.E., Haines, J.L., Sutcliffe, J.S., Genome-wide and Ordered-Subset linkage analyses provide support for autism loci on 17q and 19p with evidence of phenotypic and interlocus genetic correlates. BMC Med. Genet., 6, 2005, 1.
120. [121] Menold, M.M., Shao, Y., Wolpert, C.M., Donnelly, S.L., Raiford, K.L., Martin, E.R., Ravan, S.A., Abramson, R.K., Wright, H.H., Delong, G.R., et al. Association analysis of chromosome 15 gabaa receptor subunit genes in autistic disorder. J. Neurogenet. 15 (2001), 245–259.
121. [122] Miles, J.H., Autism spectrum disorders–a genetics review. Genet. Med. 13 (2011), 278–294.
122. [123] Morel, L., Blenman, K.R., Croker, B.P., Wakeland, E.K., The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 1787–1792.
123. [124] Morgan, J.T., Chana, G., Pardo, C.A., Achim, C., Semendeferi, K., Buckwalter, J., Courchesne, E., Everall, I.P., Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol. Psychiatry 68 (2010), 368–376.
124. [125] Mott, R., Talbot, C.J., Turri, M.G., Collins, A.C., Flint, J., A method for fine mapping quantitative trait loci in outbred animal stocks. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 12649–12654.
125. [126] Neale, B.M., Kou, Y., Liu, L., Ma'ayan, A., Samocha, K.E., Sabo, A., Lin, C.F., Stevens, C., Wang, L.S., Makarov, V., et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485 (2012), 242–245.
126. [127] Nishimura, Y., Martin, C.L., Vazquez-Lopez, A., Spence, S.J., Alvarez-Retuerto, A.I., Sigman, M., Steindler, C., Pellegrini, S., Schanen, N.C., Warren, S.T., Geschwind, D.H., Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum. Mol. Genet. 16 (2007), 1682–1698.
127. [128] O'Roak, B.J., Deriziotis, P., Lee, C., Vives, L., Schwartz, J.J., Girirajan, S., Karakoc, E., Mackenzie, A.P., Ng, S.B., Baker, C., et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat. Genet. 43 (2011), 585–589.
128. [129] O'Roak, B.J., Vives, L., Fu, W., Egertson, J.D., Stanaway, I.B., Phelps, I.G., Carvill, G., Kumar, A., Lee, C., Ankenman, K., et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338 (2012), 1619–1622.
129. [130] O'Roak, B.J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B.P., Levy, R., Ko, A., Lee, C., Smith, J.D., et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485 (2012), 246–250.
130. [131] Ott, J., Analysis of Human Genetic Linkage. Rev. edn, 1991, Johns Hopkins University Press, Baltimore.
131. [132] Pardo, C.A., Vargas, D.L., Zimmerman, A.W., Immunity, neuroglia and neuroinflammation in autism. Int. Rev. Psychiatry 17 (2005), 485–495.
132. [133] Parikshak, N.N., Luo, R., Zhang, A., Won, H., Lowe, J.K., Chandran, V., Horvath, S., Geschwind, D.H., Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 155 (2013), 1008–1021.
133. [134] Parner, E.T., Thorsen, P., Dixon, G., de Klerk, N., Leonard, H., Nassar, N., Bourke, J., Bower, C., Glasson, E.J., A comparison of autism prevalence trends in Denmark and Western Australia. J. Autism Dev. Disord. 41 (2011), 1601–1608.
134. [135] Peca, J., Feng, G., Cellular and synaptic network defects in autism. Curr. Opin. Neurobiol. 22 (2012), 866–872.
135. [136] Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R., et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6 (2000), 991–997.
136. [137] Philippe, A., Martinez, M., Guilloud-Bataille, M., Gillberg, C., Rastam, M., Sponheim, E., Coleman, M., Zappella, M., Aschauer, H., Van Maldergem, L., et al. Genome-wide scan for autism susceptibility genes. Paris autism research international Sibpair study. Hum. Mol. Genet. 8 (1999), 805–812.
137. [138] Pieretti, M., Zhang, F.P., Fu, Y.H., Warren, S.T., Oostra, B.A., Caskey, C.T., Nelson, D.L., Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66 (1991), 817–822.
138. [139] Piton, A., Jouan, L., Rochefort, D., Dobrzeniecka, S., Lachapelle, K., Dion, P.A., Gauthier, J., Rouleau, G.A., Analysis of the effects of rare variants on splicing identifies alterations in GABAA receptor genes in autism spectrum disorder individuals. European journal of human genetics. EJHG 21 (2013), 749–756.
139. [140] Pucilowska, J., Vithayathil, J., Tavares, E.J., Kelly, C., Karlo, J.C., Landreth, G.E., The 16p11.2 deletion mouse model of autism exhibits altered cortical progenitor proliferation and brain cytoarchitecture linked to the ERK MAPK pathway. J. Neurosci. Off. J. Soc. Neurosci. 35 (2015), 3190–3200.
140. [141] Puffenberger, E.G., Jinks, R.N., Wang, H., Xin, B., Fiorentini, C., Sherman, E.A., Degrazio, D., Shaw, C., Sougnez, C., Cibulskis, K., et al. A homozygous missense mutation in HERC2 associated with global developmental delay and autism spectrum disorder. Hum. Mutat. 33 (2012), 1639–1646.
141. [142] Purcell, A.E., Jeon, O.H., Zimmerman, A.W., Blue, M.E., Pevsner, J., Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57 (2001), 1618–1628.
142. [143] Risch, N., Spiker, D., Lotspeich, L., Nouri, N., Hinds, D., Hallmayer, J., Kalaydjieva, L., McCague, P., Dimiceli, S., Pitts, T., et al. A genomic screen of autism: evidence for a multilocus etiology. Am. J. Hum. Genet. 65 (1999), 493–507.
143. [144] Ronan, J.L., Wu, W., Crabtree, G.R., From neural development to cognition: unexpected roles for chromatin. Nat. Rev. Genet. 14 (2013), 347–359.
144. [145] Rube, H.T., Lee, W., Hejna, M., Chen, H., Yasui, D.H., Hess, J.F., LaSalle, J.M., Song, J.S., Gong, Q., Sequence features accurately predict genome-wide MeCP2 binding in vivo. Nat. Commun., 7, 2016, 11025.
145. [146] Rubenstein, J.L., Merzenich, M.M., Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2 (2003), 255–267.
146. [147] Sahoo, T., Theisen, A., Rosenfeld, J.A., Lamb, A.N., Ravnan, J.B., Schultz, R.A., Torchia, B.S., Neill, N., Casci, I., Bejjani, B.A., Shaffer, L.G., Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 13 (2011), 868–880.
147. [148] Salih, M.A., Murshid, W.R., Seidahmed, M.Z., Classification, clinical features, and genetics of neural tube defects. Saudi Med. J. 35:Suppl 1 (2014), S5–S14.
148. [149] Sanchez-Camacho, C., Bovolenta, P., Emerging mechanisms in morphogen-mediated axon guidance. BioEssays News Rev. Mol. Cell. Dev. Biol. 31 (2009), 1013–1025.
149. [150] Sanders, S.J., Ercan-Sencicek, A.G., Hus, V., Luo, R., Murtha, M.T., Moreno-De-Luca, D., Chu, S.H., Moreau, M.P., Gupta, A.R., Thomson, S.A., et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70 (2011), 863–885.
150. [151] Sanders, S.J., Murtha, M.T., Gupta, A.R., Murdoch, J.D., Raubeson, M.J., Willsey, A.J., Ercan-Sencicek, A.G., DiLullo, N.M., Parikshak, N.N., Stein, J.L., et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485 (2012), 237–241.
151. [152] Sarbassov, D.D., Ali, S.M., Sabatini, D.M., Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17 (2005), 596–603.
152. [153] Schain, R.J., Freedman, D.X., Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J. Pediatr. 58 (1961), 315–320.
153. [154] Schellenberg, G.D., Dawson, G., Sung, Y.J., Estes, A., Munson, J., Rosenthal, E., Rothstein, J., Flodman, P., Smith, M., Coon, H., et al. Evidence for multiple loci from a genome scan of autism kindreds. Mol. Psychiatry 11 (2006), 1049–1060 1979.
154. [155] Schizophrenia Working Group of the Psychiatric Genomics, C, Biological insights from 108 schizophrenia-associated genetic loci. Nature 511 (2014), 421–427.
155. [156] Schumann, C.M., Amaral, D.G., Stereological analysis of amygdala neuron number in autism. J. Neurosci. Off. J. Soc. Neurosci. 26 (2006), 7674–7679.
156. [157] Scott-Van Zeeland, A.A., Abrahams, B.S., Alvarez-Retuerto, A.I., Sonnenblick, L.I., Rudie, J.D., Ghahremani, D., Mumford, J.A., Poldrack, R.A., Dapretto, M., Geschwind, D.H., Bookheimer, S.Y., Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2. Sci. Transl. Med., 2, 2010 56ra80.
157. [158] Shao, H., Sinasac, D.S., Burrage, L.C., Hodges, C.A., Supelak, P.J., Palmert, M.R., Moreno, C., Cowley, A.W. Jr., Jacob, H.J., Nadeau, J.H., Analyzing complex traits with congenic strains. Mamm. Genome Off. J. Int. Mamm. Genome Soc. 21 (2010), 276–286.
158. [159] Shimabukuro, T.T., Grosse, S.D., Rice, C., Medical expenditures for children with an autism spectrum disorder in a privately insured population. J. Autism Dev. Disord. 38 (2008), 546–552.
159. [160] Shinohe, A., Hashimoto, K., Nakamura, K., Tsujii, M., Iwata, Y., Tsuchiya, K.J., Sekine, Y., Suda, S., Suzuki, K., Sugihara, G., et al. Increased serum levels of glutamate in adult patients with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 (2006), 1472–1477.
160. [161] Shultz, K.L., Donahue, L.R., Bouxsein, M.L., Baylink, D.J., Rosen, C.J., Beamer, W.G., Congenic strains of mice for verification and genetic decomposition of quantitative trait loci for femoral bone mineral density. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 18 (2003), 175–185.
161. [162] Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 (2007), 881–885.
162. [163] Spillane, J., Kullmann, D.M., Hanna, M.G., Genetic neurological channelopathies: molecular genetics and clinical phenotypes. J. Neurol., Neurosurg. Psychiatry 87 (2016), 37–48.
163. [164] Splawski, I., Timothy, K.W., Sharpe, L.M., Decher, N., Kumar, P., Bloise, R., Napolitano, C., Schwartz, P.J., Joseph, R.M., Condouris, K., et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119 (2004), 19–31.
164. [165] Stein, J.L., Parikshak, N.N., Geschwind, D.H., Rare inherited variation in autism: beginning to see the forest and a few trees. Neuron 77 (2013), 209–211.
165. [166] Stoner, R., Chow, M.L., Boyle, M.P., Sunkin, S.M., Mouton, P.R., Roy, S., Wynshaw-Boris, A., Colamarino, S.A., Lein, E.S., Courchesne, E., Patches of disorganization in the neocortex of children with autism. N. Engl. J. Med. 370 (2014), 1209–1219.
166. [167] Stranger, B.E., Stahl, E.A., Raj, T., Progress and promise of genome-wide association studies for human complex trait genetics. Genetics 187 (2011), 367–383.
167. [168] Suliman, R., Ben-David, E., Shifman, S., Chromatin regulators, phenotypic robustness, and autism risk. Front. Genet., 5, 2014, 81.
168. [169] Talkowski, M.E., Rosenfeld, J.A., Blumenthal, I., Pillalamarri, V., Chiang, C., Heilbut, A., Ernst, C., Hanscom, C., Rossin, E., Lindgren, A.M., et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 149 (2012), 525–537.
169. [170] Tetreault, N.A., Hakeem, A.Y., Jiang, S., Williams, B.A., Allman, E., Wold, B.J., Allman, J.M., Microglia in the cerebral cortex in autism. J. Autism Dev. Disord. 42 (2012), 2569–2584.
170. [171] Thomas, J.A., Johnson, J., Peterson Kraai, T.L., Wilson, R., Tartaglia, N., LeRoux, J., Beischel, L., McGavran, L., Hagerman, R.J., Genetic and clinical characterization of patients with an interstitial duplication 15q11-q13, emphasizing behavioral phenotype and response to treatment. Am. J. Med. Genet. Part A 119A (2003), 111–120.
171. [172] Tick, B., Bolton, P., Happe, F., Rutter, M., Rijsdijk, F., Heritability of autism spectrum disorders: a meta-analysis of twin studies. J. Child Psychol. Psychiatry 57 (2016), 585–595.
172. [173] Turner, T.N., Hormozdiari, F., Duyzend, M.H., McClymont, S.A., Hook, P.W., Iossifov, I., Raja, A., Baker, C., Hoekzema, K., Stessman, H.A., et al. Genome sequencing of autism-affected families reveals disruption of putative noncoding regulatory DNA. Am. J. Hum. Genet. 98 (2016), 58–74.
173. [174] Uddin, M., Tammimies, K., Pellecchia, G., Alipanahi, B., Hu, P., Wang, Z., Pinto, D., Lau, L., Nalpathamkalam, T., Marshall, C.R., et al. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder. Nat. Genet. 46 (2014), 742–747.
174. [175] Voineagu, I., Wang, X., Johnston, P., Lowe, J.K., Tian, Y., Horvath, S., Mill, J., Cantor, R.M., Blencowe, B.J., Geschwind, D.H., Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474 (2011), 380–384.
175. [176] Vorstman, J.A., Spooren, W., Persico, A.M., Collier, D.A., Aigner, S., Jagasia, R., Glennon, J.C., Buitelaar, J.K., Using genetic findings in autism for the development of new pharmaceutical compounds. Psychopharmacology 231 (2014), 1063–1078.
176. [177] Wang, K., Zhang, H., Ma, D., Bucan, M., Glessner, J.T., Abrahams, B.S., Salyakina, D., Imielinski, M., Bradfield, J.P., Sleiman, P.M., et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 459 (2009), 528–533.
177. [178] Weiss, L.A., Arking, D.E., Gene Discovery Project of Johns, H., the Autism, C., Daly, M.J., Chakravarti, A., A genome-wide linkage and association scan reveals novel loci for autism. Nature 461 (2009), 802–808.
178. [179] Weiss, L.A., Shen, Y., Korn, J.M., Arking, D.E., Miller, D.T., Fossdal, R., Saemundsen, E., Stefansson, H., Ferreira, M.A., Green, T., et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358 (2008), 667–675.
179. [180] Wellcome Trust Case Control, C, Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007), 661–678.
180. [181] Willsey, A.J., Sanders, S.J., Li, M., Dong, S., Tebbenkamp, A.T., Muhle, R.A., Reilly, S.K., Lin, L., Fertuzinhos, S., Miller, J.A., et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 155 (2013), 997–1007.
181. [182] Willsey, A.J., State, M.W., Autism spectrum disorders: from genes to neurobiology. Curr. Opin. Neurobiol. 30 (2015), 92–99.
182. [183] Wolff, S., The history of autism. Eur. Child. Adolesc. Psychiatry 13 (2004), 201–208.
183. [184] Wong, V.C., Hui, S.L., Epidemiological study of autism spectrum disorder in China. J. Child. Neurol. 23 (2008), 67–72.
184. [185] Xu, X., Wells, A.B., O'Brien, D.R., Nehorai, A., Dougherty, J.D., Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders. J. Neurosci. Off. J. Soc. Neurosci. 34 (2014), 1420–1431.
185. [186] Yamazaki, K., McGovern, D., Ragoussis, J., Paolucci, M., Butler, H., Jewell, D., Cardon, L., Takazoe, M., Tanaka, T., Ichimori, T., et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum. Mol. Genet. 14 (2005), 3499–3506.
186. [187] Yonan, A.L., Alarcon, M., Cheng, R., Magnusson, P.K., Spence, S.J., Palmer, A.A., Grunn, A., Juo, S.H., Terwilliger, J.D., Liu, J., et al. A genomewide screen of 345 families for autism-susceptibility loci. Am. J. Hum. Genet. 73 (2003), 886–897.
187. [188] Zielinski, B.A., Prigge, M.B., Nielsen, J.A., Froehlich, A.L., Abildskov, T.J., Anderson, J.S., Fletcher, P.T., Zygmunt, K.M., Travers, B.G., Lange, N., et al. Longitudinal changes in cortical thickness in autism and typical development. Brain a J. Neurol. 137 (2014), 1799–1812.
188. [189] Zoghbi, H.Y., Bear, M.F., Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb. Perspect. Biol., 4, 2012.